Proteolytic Activities and Immunological Effects of Light Chains of Botulinum Neurotoxin A1, A2 and A3 Subtypes. [PDF]
Liao Y +6 more
europepmc +1 more source
Cell-Penetrating Botulinum Neurotoxin Type A Proteins Alleviate Skeletal Muscle Hypertrophy with Associated Alterations of Mitochondrial Homeostasis. [PDF]
Li L, Wei X, Jiang L, Gao Z, Liu J.
europepmc +1 more source
Upper-limb range of motion in children with cerebral palsy treated with botulinum neurotoxin: a population-based cohort study. [PDF]
Hedberg-Graff J +4 more
europepmc +1 more source
AI-Based Quantification of Botulinum Neurotoxin-Induced Facial Changes: Wrinkle Reduction, Region-Specific Effects, and Functional Correlates of Facial Muscle Activity. [PDF]
Güler I, Kraus A, Grieb G, Stelling H.
europepmc +1 more source
Botulinum Neurotoxin A Injections in Spasmodic Entropion: A Clinical Retrospective Cohort Study. [PDF]
Girard B, Carré F, Begnaud S.
europepmc +1 more source
Characterisation of the SNAP-25 and SNAP-23 cleavage properties of the botulinum neurotoxin-like protein from Enterococcus. [PDF]
Henke T +3 more
europepmc +1 more source
Feasibility and structure of a state hospital botulinum neurotoxin clinic for clozapine-induced sialorrhea. [PDF]
Arias AW +3 more
europepmc +1 more source
A nut-and-bolt assembly of the bimodular large progenitor botulinum neurotoxin complex. [PDF]
Lam KH +11 more
europepmc +1 more source
Sonoanatomy of the Nasal Ala for Botulinum Neurotoxin Injection. [PDF]
Yi KH +6 more
europepmc +1 more source
Systematic Review and Meta-Analysis of Secondary Treatment Failure and Immunogenicity with Botulinum Neurotoxin A in Multiple Indications-Comment on Recommending IncobotulinumtoxinA as First-Line to Prevent Secondary Treatment Failure [Letter]. [PDF]
Magacho-Vieira FN.
europepmc +1 more source

